Bristol-Myers Squibb Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
175 result(s) found, displaying 61 to 70
-
Prescription medicine registrationActive ingredients: dasatinib.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nivolumab
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nivolumab
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment for Dasatinib
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EMPLICITI elotuzumab 400mg lyophilized powder for IV infusion vial.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Abatacept
-
Designation or determinationOrphan drug
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd